The identification of immunodominant T cell epitopes and the newly developed mouse MHC class I and class II tetramers will allow the RHV mouse model to define the liver-specific antiviral response that shapes the nature of liver-resident T cells and the divergent outcomes of hepatotropic infections. The gene discussed is HLA-C; the disease is infection.